Name | Type | Posted | Actions |
|---|---|---|---|
36C24926A0041_1.docx | DOCX | May 26, 2026 |
6550--Roche Ventana IHC/SS Mt Home VAMC Blanket Purchase Agreement Sole Source Notice IAW FAR 12.102(b) Estimated Value
Contact and place of performance
Robert Pitre
Not specified
VHAPG Part 806.3 OFOC Page 1 of 4 Revision: 04 Effective Date: 12/15/25 Acquisition ID#: 36C249-26-AP-1835 DEPARTMENT OF VETERANS AFFAIRS Justification and Approval (J&A) For Other Than Full and Open Competition (>SAT) IAW FAR Overhaul Part 12.102(b) Acquisition Plan Action ID: 36C249-26-AP-1835 Contracting Activity: Department of Veterans Affairs, Network Contracting Office 9 on behalf of VISN 9, James H. Quillen VA...
View moreThe Department of Veterans Affairs, Network Contracting Office 9, issued a Justification and Approval for a sole source procurement on behalf of the James H. Quillen VA Medical Center in Mountain Home, Tennessee. This action establishes a 24-month Blanket Purchase Agreement with Roche Diagnostics Corporation for the rental of two Roche-VENTANA BenchMark ULTRA PLUS Immunohistochemical Stainers and one Benchmark Special Stainer. The agreement, identified by solicitation number 36C24926AP1835 and an estimated value of $880,000, covers all necessary reagents, stains, antibodies, consumables, and technical support. The period of performance is scheduled from June 1, 2026, to May 30, 2028.
This acquisition is classified under NAICS 325413 for In-Vitro Diagnostic Substance Manufacturing and PSC 6550 for In Vitro Diagnostic Substances, Reagents, Test Kits and Sets. The procurement is conducted under the authority of 41 U.S.C. 1901, citing that only one responsible source can satisfy the agency's requirements. The Roche-VENTANA platform was selected because it allows operators to add or remove slides and reagents via individual drawers without interrupting the workflow or requiring batch runs. This capability prevents delays in patient tissue staining and subsequent diagnosis while fitting within the facility’s restrictive laboratory space.
The Histology section of the Pathology and Laboratory Medicine Service will utilize these systems to produce quality stained slides for pathological evaluation. Market research indicated that this requirement has consistently been sole-sourced across various government agencies, as the Roche system is the only platform that eliminates the risk of accidental use of expired reagents and mislabeling through its automated entry features. Robert Pitre is the designated point of contact for this notice, which was published on May 26, 2026, and includes one attached justification document.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.